> top > docs > PMC:1310901 > spans > 13058-14324 > annotations

PMC:1310901 / 13058-14324 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-reference-eval

Id Subject Object Predicate Lexical cue
T6887 0-7 Negative_regulation denotes Absence
T6888 513-521 Gene_expression denotes positive
T6889 616-624 Gene_expression denotes positive
T6890 724-731 Negative_regulation denotes absence
T6891 741-751 Gene_expression denotes expression
T6892 912-920 Gene_expression denotes positive
T6893 942-950 Gene_expression denotes negative
T6894 17-27 Gene_expression denotes expression
T6895 53-56 Positive_regulation denotes due
T6896 115-119 Negative_regulation denotes lack
T6897 129-139 Gene_expression denotes expression
T6898 240-250 Gene_expression denotes expression
T6899 341-349 Gene_expression denotes positive
T6900 380-387 Gene_expression denotes positve
T6901 460-467 Gene_expression denotes positve
T6902 11-16 Protein denotes IRF-4
T6903 735-740 Protein denotes IRF-4
T6904 906-911 Protein denotes IRF-4
T6905 936-941 Protein denotes IRF-4
T6906 123-128 Protein denotes IRF-4
T6907 234-239 Protein denotes IRF-4
T6908 333-340 Protein denotes bcr-abl
T6909 372-379 Protein denotes bcr-abl
T6910 452-459 Protein denotes bcr-abl
T6911 505-512 Protein denotes bcr-abl
T6912 608-615 Protein denotes bcr-abl
T6913 682-687 Protein denotes IRF-4
R5743 T6887 T6895 themeOf Absence,due
R5744 T6891 T6890 themeOf expression,absence
R5745 T6894 T6887 themeOf expression,Absence
R5746 T6897 T6896 themeOf expression,lack
R5747 T6902 T6894 themeOf IRF-4,expression
R5748 T6903 T6891 themeOf IRF-4,expression
R5749 T6904 T6892 themeOf IRF-4,positive
R5750 T6905 T6893 themeOf IRF-4,negative
R5751 T6906 T6897 themeOf IRF-4,expression
R5752 T6907 T6898 themeOf IRF-4,expression
R5753 T6908 T6899 themeOf bcr-abl,positive
R5754 T6909 T6900 themeOf bcr-abl,positve
R5755 T6910 T6901 themeOf bcr-abl,positve
R5756 T6911 T6888 themeOf bcr-abl,positive
R5757 T6912 T6889 themeOf bcr-abl,positive

events-check-again

Id Subject Object Predicate Lexical cue Negation Speculation
T6817 0-7 Negative_regulation denotes Absence
T6818 11-16 Protein denotes IRF-4
T6819 17-27 Gene_expression denotes expression
T6820 53-56 Positive_regulation denotes due true
T6821 115-119 Negative_regulation denotes lack
T6822 123-128 Protein denotes IRF-4
T6823 129-139 Gene_expression denotes expression
T6824 234-239 Protein denotes IRF-4
T6825 240-250 Gene_expression denotes expression true
T6826 333-340 Protein denotes bcr-abl
T6827 341-349 Gene_expression denotes positive
T6828 372-379 Protein denotes bcr-abl
T6829 380-387 Gene_expression denotes positve
T6830 452-459 Protein denotes bcr-abl
T6831 460-467 Gene_expression denotes positve
T6832 505-512 Protein denotes bcr-abl
T6833 513-521 Gene_expression denotes positive
T6834 608-615 Protein denotes bcr-abl
T6835 616-624 Gene_expression denotes positive
T6836 682-687 Protein denotes IRF-4
T6837 724-731 Negative_regulation denotes absence
T6838 735-740 Protein denotes IRF-4
T6839 741-751 Gene_expression denotes expression
T6840 906-911 Protein denotes IRF-4
T6841 912-920 Gene_expression denotes positive
T6842 936-941 Protein denotes IRF-4
T6843 942-950 Gene_expression denotes negative true
T6844 1242-1248 Regulation denotes affect true true
T6845 1249-1254 Protein denotes IRF-4
T6846 1255-1265 Gene_expression denotes expression
R5705 T6817 T6820 themeOf Absence,due
R5706 T6818 T6819 themeOf IRF-4,expression
R5707 T6819 T6817 themeOf expression,Absence
R5708 T6822 T6823 themeOf IRF-4,expression
R5709 T6823 T6821 themeOf expression,lack
R5710 T6824 T6825 themeOf IRF-4,expression
R5711 T6826 T6827 themeOf bcr-abl,positive
R5712 T6828 T6829 themeOf bcr-abl,positve
R5713 T6830 T6831 themeOf bcr-abl,positve
R5714 T6832 T6833 themeOf bcr-abl,positive
R5715 T6834 T6835 themeOf bcr-abl,positive
R5716 T6838 T6839 themeOf IRF-4,expression
R5717 T6839 T6837 themeOf expression,absence
R5718 T6840 T6841 themeOf IRF-4,positive
R5719 T6842 T6843 themeOf IRF-4,negative
R5720 T6845 T6846 themeOf IRF-4,expression
R5721 T6846 T6844 themeOf expression,affect

GO-CC

Id Subject Object Predicate Lexical cue
T6720 40-45 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6721 187-192 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6722 276-280 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T6723 308-312 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T6724 352-356 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T6725 627-631 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T6726 772-776 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T6214 0-80 Sentence denotes Absence of IRF-4 expression in leukemia cells is not due to promoter alterations
T6215 81-197 Sentence denotes We have previously demonstrated a lack of IRF-4 expression in leukemia patients and specifically in CML T-cells (3).
T6216 198-657 Sentence denotes Here, we demonstrate the absence of IRF-4 expression in various hematopoietic cell lines, such as Jurkat, a T-cell leukemia, CML-T1, a bcr-abl-positive T-cell line, K-562, a bcr-abl-positve erythroleukemia, U-937, a monocytic leukemia, EM-2 and LAMA-84, bcr-abl-positve myeloid leukemia, but not in SD-1, a bcr-abl-positive acute lymphoblastic leukemia (pre B-ALL), RPMI-8226, a multiple myeloma and BV-173, a bcr-abl-positive B-cell line (Figures 1A and 5D).
T6217 658-814 Sentence denotes After sequencing of the IRF-4 promoter, it could be excluded that absence of IRF-4 expression in any of the above cell lines was due to genetic aberrations.
T6218 815-987 Sentence denotes However, 2 bp changes (nucleotide −1081, T→C and −1068, A→C) could be detected in both the IRF-4-positive BV-173 and the IRF-4-negative LAMA-84, EM-2 and K-562 (Figure 1B).
T6219 988-1193 Sentence denotes At position −116 an A→C substitution was found in EM-2, K-562 and CML-T1, whereas Jurkat, BV-173 and SD-1 exhibited a mixed A/C sequence and U-937, LAMA-84 and RPMI-8226 no substitution at all (Figure 1B).
T6220 1194-1266 Sentence denotes Consequently, these alterations are unlikely to affect IRF-4 expression.
T101 0-80 Sentence denotes Absence of IRF-4 expression in leukemia cells is not due to promoter alterations
T102 81-197 Sentence denotes We have previously demonstrated a lack of IRF-4 expression in leukemia patients and specifically in CML T-cells (3).
T103 198-657 Sentence denotes Here, we demonstrate the absence of IRF-4 expression in various hematopoietic cell lines, such as Jurkat, a T-cell leukemia, CML-T1, a bcr-abl-positive T-cell line, K-562, a bcr-abl-positve erythroleukemia, U-937, a monocytic leukemia, EM-2 and LAMA-84, bcr-abl-positve myeloid leukemia, but not in SD-1, a bcr-abl-positive acute lymphoblastic leukemia (pre B-ALL), RPMI-8226, a multiple myeloma and BV-173, a bcr-abl-positive B-cell line (Figures 1A and 5D).
T104 658-814 Sentence denotes After sequencing of the IRF-4 promoter, it could be excluded that absence of IRF-4 expression in any of the above cell lines was due to genetic aberrations.
T105 815-987 Sentence denotes However, 2 bp changes (nucleotide −1081, T→C and −1068, A→C) could be detected in both the IRF-4-positive BV-173 and the IRF-4-negative LAMA-84, EM-2 and K-562 (Figure 1B).
T106 988-1193 Sentence denotes At position −116 an A→C substitution was found in EM-2, K-562 and CML-T1, whereas Jurkat, BV-173 and SD-1 exhibited a mixed A/C sequence and U-937, LAMA-84 and RPMI-8226 no substitution at all (Figure 1B).
T107 1194-1266 Sentence denotes Consequently, these alterations are unlikely to affect IRF-4 expression.

2_test

Id Subject Object Predicate Lexical cue
16396836-11013272-76538192 194-195 11013272 denotes 3

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T6221 0-7 NN denotes Absence
T6222 8-10 IN denotes of
T6223 11-16 NN denotes IRF-4
T6224 17-27 NN denotes expression
T6225 28-30 IN denotes in
T6226 31-39 NN denotes leukemia
T6227 40-45 NN denotes cells
T6228 46-48 VB denotes is
T6229 49-52 RB denotes not
T6230 53-56 JJ denotes due
T6231 57-59 TO denotes to
T6232 60-68 NN denotes promoter
T6233 69-80 NN denotes alterations
T6234 81-83 PRP denotes We
T6235 84-88 VB denotes have
T6236 89-99 RB denotes previously
T6237 100-112 VB denotes demonstrated
T6238 113-114 DT denotes a
T6239 115-119 NN denotes lack
T6240 120-122 IN denotes of
T6241 123-128 NN denotes IRF-4
T6242 129-139 NN denotes expression
T6243 140-142 IN denotes in
T6244 143-151 NN denotes leukemia
T6245 152-160 NN denotes patients
T6246 161-164 CC denotes and
T6247 165-177 RB denotes specifically
T6248 178-180 IN denotes in
T6249 181-184 NN denotes CML
T6250 185-192 NN denotes T-cells
T6251 193-194 -LRB- denotes (
T6252 194-195 CD denotes 3
T6253 195-196 -RRB- denotes )
T6254 198-202 RB denotes Here
T6255 202-203 -COMMA- denotes ,
T6256 204-206 PRP denotes we
T6257 207-218 VB denotes demonstrate
T6258 219-222 DT denotes the
T6259 223-230 NN denotes absence
T6260 231-233 IN denotes of
T6261 234-239 NN denotes IRF-4
T6262 240-250 NN denotes expression
T6263 251-253 IN denotes in
T6264 254-261 JJ denotes various
T6265 262-275 JJ denotes hematopoietic
T6266 276-280 NN denotes cell
T6267 281-286 NN denotes lines
T6268 286-287 -COMMA- denotes ,
T6269 288-292 JJ denotes such
T6270 293-295 IN denotes as
T6271 296-302 NN denotes Jurkat
T6272 302-303 -COMMA- denotes ,
T6273 304-305 DT denotes a
T6274 306-312 NN denotes T-cell
T6275 313-321 NN denotes leukemia
T6276 321-322 -COMMA- denotes ,
T6277 323-329 NN denotes CML-T1
T6278 329-330 -COMMA- denotes ,
T6279 331-332 DT denotes a
T6280 333-349 JJ denotes bcr-abl-positive
T6281 350-356 NN denotes T-cell
T6282 357-361 NN denotes line
T6283 361-362 -COMMA- denotes ,
T6284 363-368 NN denotes K-562
T6285 368-369 -COMMA- denotes ,
T6286 370-371 DT denotes a
T6287 372-387 JJ denotes bcr-abl-positve
T6288 388-403 NN denotes erythroleukemia
T6289 403-404 -COMMA- denotes ,
T6290 405-410 NN denotes U-937
T6291 410-411 -COMMA- denotes ,
T6292 412-413 DT denotes a
T6293 414-423 JJ denotes monocytic
T6294 424-432 NN denotes leukemia
T6295 432-433 -COMMA- denotes ,
T6296 434-438 NN denotes EM-2
T6297 439-442 CC denotes and
T6298 443-450 NN denotes LAMA-84
T6299 450-451 -COMMA- denotes ,
T6300 452-467 JJ denotes bcr-abl-positve
T6301 468-475 JJ denotes myeloid
T6302 476-484 NN denotes leukemia
T6303 484-485 -COMMA- denotes ,
T6304 486-489 CC denotes but
T6305 490-493 RB denotes not
T6306 494-496 IN denotes in
T6307 497-501 NN denotes SD-1
T6308 501-502 -COMMA- denotes ,
T6309 503-504 DT denotes a
T6310 505-521 JJ denotes bcr-abl-positive
T6311 522-527 JJ denotes acute
T6312 528-541 JJ denotes lymphoblastic
T6313 542-550 NN denotes leukemia
T6314 551-552 -LRB- denotes (
T6315 552-555 JJ denotes pre
T6316 556-561 NN denotes B-ALL
T6317 561-562 -RRB- denotes )
T6318 562-563 -COMMA- denotes ,
T6319 564-573 NN denotes RPMI-8226
T6320 573-574 -COMMA- denotes ,
T6321 575-576 DT denotes a
T6322 577-585 JJ denotes multiple
T6323 586-593 NN denotes myeloma
T6324 594-597 CC denotes and
T6325 598-604 NN denotes BV-173
T6326 604-605 -COMMA- denotes ,
T6327 606-607 DT denotes a
T6328 608-624 JJ denotes bcr-abl-positive
T6329 625-631 NN denotes B-cell
T6330 632-636 NN denotes line
T6331 637-638 -LRB- denotes (
T6332 638-645 NN denotes Figures
T6333 646-648 NN denotes 1A
T6334 649-652 CC denotes and
T6335 653-655 NN denotes 5D
T6336 655-656 -RRB- denotes )
T6337 658-663 IN denotes After
T6338 664-674 NN denotes sequencing
T6339 675-677 IN denotes of
T6340 678-681 DT denotes the
T6341 682-687 NN denotes IRF-4
T6342 688-696 NN denotes promoter
T6343 696-697 -COMMA- denotes ,
T6344 698-700 PRP denotes it
T6345 701-706 MD denotes could
T6346 707-709 VB denotes be
T6347 710-718 VB denotes excluded
T6348 719-723 IN denotes that
T6349 724-731 NN denotes absence
T6350 732-734 IN denotes of
T6351 735-740 NN denotes IRF-4
T6352 741-751 NN denotes expression
T6353 752-754 IN denotes in
T6354 755-758 DT denotes any
T6355 759-761 IN denotes of
T6356 762-765 DT denotes the
T6357 766-771 JJ denotes above
T6358 772-776 NN denotes cell
T6359 777-782 NN denotes lines
T6360 783-786 VB denotes was
T6361 787-790 JJ denotes due
T6362 791-793 TO denotes to
T6363 794-801 JJ denotes genetic
T6364 802-813 NN denotes aberrations
T6365 815-822 RB denotes However
T6366 822-823 -COMMA- denotes ,
T6367 824-825 CD denotes 2
T6368 826-828 NN denotes bp
T6369 829-836 NN denotes changes
T6370 837-838 -LRB- denotes (
T6371 838-848 NN denotes nucleotide
T6372 849-854 NN denotes −1081
T6373 854-855 -COMMA- denotes ,
T6374 856-859 NN denotes T→C
T6375 860-863 CC denotes and
T6376 864-869 CD denotes −1068
T6377 869-870 -COMMA- denotes ,
T6378 871-874 NN denotes A→C
T6379 874-875 -RRB- denotes )
T6380 876-881 MD denotes could
T6381 882-884 VB denotes be
T6382 885-893 VB denotes detected
T6383 894-896 IN denotes in
T6384 897-901 CC denotes both
T6385 902-905 DT denotes the
T6386 906-920 JJ denotes IRF-4-positive
T6387 921-927 NN denotes BV-173
T6388 928-931 CC denotes and
T6389 932-935 DT denotes the
T6390 936-950 JJ denotes IRF-4-negative
T6391 951-958 NN denotes LAMA-84
T6392 958-959 -COMMA- denotes ,
T6393 960-964 NN denotes EM-2
T6394 965-968 CC denotes and
T6395 969-974 NN denotes K-562
T6396 975-976 -LRB- denotes (
T6397 976-982 NN denotes Figure
T6398 983-985 NN denotes 1B
T6399 985-986 -RRB- denotes )
T6400 988-990 IN denotes At
T6401 991-999 NN denotes position
T6402 1000-1004 CD denotes −116
T6403 1005-1007 DT denotes an
T6404 1008-1011 NN denotes A→C
T6405 1012-1024 NN denotes substitution
T6406 1025-1028 VB denotes was
T6407 1029-1034 VB denotes found
T6408 1035-1037 IN denotes in
T6409 1038-1042 NN denotes EM-2
T6410 1042-1043 -COMMA- denotes ,
T6411 1044-1049 NN denotes K-562
T6412 1050-1053 CC denotes and
T6413 1054-1060 NN denotes CML-T1
T6414 1060-1061 -COMMA- denotes ,
T6415 1062-1069 IN denotes whereas
T6416 1070-1076 NN denotes Jurkat
T6417 1076-1077 -COMMA- denotes ,
T6418 1078-1084 NN denotes BV-173
T6419 1085-1088 CC denotes and
T6420 1089-1093 NN denotes SD-1
T6421 1094-1103 VB denotes exhibited
T6422 1104-1105 DT denotes a
T6423 1106-1111 VB denotes mixed
T6424 1112-1115 NN denotes A/C
T6425 1116-1124 NN denotes sequence
T6426 1125-1128 CC denotes and
T6427 1129-1134 NN denotes U-937
T6428 1134-1135 -COMMA- denotes ,
T6429 1136-1143 NN denotes LAMA-84
T6430 1144-1147 CC denotes and
T6431 1148-1157 NN denotes RPMI-8226
T6432 1158-1160 DT denotes no
T6433 1161-1173 NN denotes substitution
T6434 1174-1176 IN denotes at
T6435 1177-1180 DT denotes all
T6436 1181-1182 -LRB- denotes (
T6437 1182-1188 NN denotes Figure
T6438 1189-1191 NN denotes 1B
T6439 1191-1192 -RRB- denotes )
T6440 1194-1206 RB denotes Consequently
T6441 1206-1207 -COMMA- denotes ,
T6442 1208-1213 DT denotes these
T6443 1214-1225 NN denotes alterations
T6444 1226-1229 VB denotes are
T6445 1230-1238 JJ denotes unlikely
T6446 1239-1241 TO denotes to
T6447 1242-1248 VB denotes affect
T6448 1249-1254 NN denotes IRF-4
T6449 1255-1265 NN denotes expression
R5176 T6221 T6222 arg1Of Absence,of
R5177 T6221 T6228 arg1Of Absence,is
R5178 T6221 T6230 arg1Of Absence,due
R5179 T6224 T6222 arg2Of expression,of
R5180 T6224 T6223 arg1Of expression,IRF-4
R5181 T6224 T6225 arg1Of expression,in
R5182 T6227 T6225 arg2Of cells,in
R5183 T6227 T6226 arg1Of cells,leukemia
R5184 T6228 T6229 arg1Of is,not
R5185 T6230 T6228 arg2Of due,is
R5186 T6230 T6231 arg1Of due,to
R5187 T6233 T6231 arg2Of alterations,to
R5188 T6233 T6232 arg1Of alterations,promoter
R5189 T6234 T6235 arg1Of We,have
R5190 T6234 T6237 arg1Of We,demonstrated
R5191 T6237 T6235 arg2Of demonstrated,have
R5192 T6237 T6236 arg1Of demonstrated,previously
R5193 T6239 T6237 arg2Of lack,demonstrated
R5194 T6239 T6238 arg1Of lack,a
R5195 T6239 T6240 arg1Of lack,of
R5196 T6239 T6243 arg1Of lack,in
R5197 T6239 T6248 arg1Of lack,in
R5198 T6242 T6240 arg2Of expression,of
R5199 T6242 T6241 arg1Of expression,IRF-4
R5200 T6243 T6246 arg1Of in,and
R5201 T6245 T6243 arg2Of patients,in
R5202 T6245 T6244 arg1Of patients,leukemia
R5203 T6248 T6246 arg2Of in,and
R5204 T6248 T6247 arg1Of in,specifically
R5205 T6250 T6248 arg2Of T-cells,in
R5206 T6250 T6249 arg1Of T-cells,CML
R5207 T6250 T6251 arg1Of T-cells,(
R5208 T6252 T6251 arg2Of 3,(
R5209 T6253 T6251 arg3Of ),(
R5210 T6256 T6257 arg1Of we,demonstrate
R5211 T6257 T6254 arg1Of demonstrate,Here
R5212 T6257 T6255 arg1Of demonstrate,","
R5213 T6259 T6258 arg1Of absence,the
R5214 T6259 T6260 arg1Of absence,of
R5215 T6259 T6306 arg1Of absence,in
R5216 T6259 T6318 arg1Of absence,","
R5217 T6259 T6324 arg1Of absence,and
R5218 T6260 T6304 arg1Of of,but
R5219 T6262 T6260 arg2Of expression,of
R5220 T6262 T6261 arg1Of expression,IRF-4
R5221 T6262 T6263 arg1Of expression,in
R5222 T6262 T6278 arg1Of expression,","
R5223 T6262 T6289 arg1Of expression,","
R5224 T6262 T6291 arg1Of expression,","
R5225 T6267 T6263 arg2Of lines,in
R5226 T6267 T6264 arg1Of lines,various
R5227 T6267 T6265 arg1Of lines,hematopoietic
R5228 T6267 T6266 arg1Of lines,cell
R5229 T6267 T6268 arg1Of lines,","
R5230 T6267 T6270 arg1Of lines,as
R5231 T6270 T6269 arg1Of as,such
R5232 T6271 T6270 arg2Of Jurkat,as
R5233 T6271 T6272 arg1Of Jurkat,","
R5234 T6271 T6276 arg1Of Jurkat,","
R5235 T6275 T6272 arg2Of leukemia,","
R5236 T6275 T6273 arg1Of leukemia,a
R5237 T6275 T6274 arg1Of leukemia,T-cell
R5238 T6277 T6276 arg2Of CML-T1,","
R5239 T6282 T6278 arg2Of line,","
R5240 T6282 T6279 arg1Of line,a
R5241 T6282 T6280 arg1Of line,bcr-abl-positive
R5242 T6282 T6281 arg1Of line,T-cell
R5243 T6282 T6283 arg1Of line,","
R5244 T6282 T6285 arg1Of line,","
R5245 T6284 T6283 arg2Of K-562,","
R5246 T6288 T6285 arg2Of erythroleukemia,","
R5247 T6288 T6286 arg1Of erythroleukemia,a
R5248 T6288 T6287 arg1Of erythroleukemia,bcr-abl-positve
R5249 T6290 T6289 arg2Of U-937,","
R5250 T6294 T6295 arg1Of leukemia,","
R5251 T6295 T6297 arg1Of ",",and
R5252 T6296 T6295 arg2Of EM-2,","
R5253 T6297 T6293 arg1Of and,monocytic
R5254 T6297 T6299 arg1Of and,","
R5255 T6298 T6297 arg2Of LAMA-84,and
R5256 T6299 T6291 arg2Of ",",","
R5257 T6299 T6292 arg1Of ",",a
R5258 T6302 T6299 arg2Of leukemia,","
R5259 T6302 T6300 arg1Of leukemia,bcr-abl-positve
R5260 T6302 T6301 arg1Of leukemia,myeloid
R5261 T6304 T6303 arg1Of but,","
R5262 T6306 T6304 arg2Of in,but
R5263 T6306 T6305 arg1Of in,not
R5264 T6307 T6306 arg2Of SD-1,in
R5265 T6307 T6308 arg1Of SD-1,","
R5266 T6313 T6308 arg2Of leukemia,","
R5267 T6313 T6309 arg1Of leukemia,a
R5268 T6313 T6310 arg1Of leukemia,bcr-abl-positive
R5269 T6313 T6311 arg1Of leukemia,acute
R5270 T6313 T6312 arg1Of leukemia,lymphoblastic
R5271 T6313 T6314 arg1Of leukemia,(
R5272 T6316 T6314 arg2Of B-ALL,(
R5273 T6316 T6315 arg1Of B-ALL,pre
R5274 T6317 T6314 arg3Of ),(
R5275 T6319 T6318 arg2Of RPMI-8226,","
R5276 T6319 T6320 arg1Of RPMI-8226,","
R5277 T6323 T6320 arg2Of myeloma,","
R5278 T6323 T6321 arg1Of myeloma,a
R5279 T6323 T6322 arg1Of myeloma,multiple
R5280 T6324 T6257 arg2Of and,demonstrate
R5281 T6325 T6324 arg2Of BV-173,and
R5282 T6325 T6326 arg1Of BV-173,","
R5283 T6330 T6326 arg2Of line,","
R5284 T6330 T6327 arg1Of line,a
R5285 T6330 T6328 arg1Of line,bcr-abl-positive
R5286 T6330 T6329 arg1Of line,B-cell
R5287 T6330 T6331 arg1Of line,(
R5288 T6333 T6334 arg1Of 1A,and
R5289 T6334 T6331 arg2Of and,(
R5290 T6334 T6332 arg1Of and,Figures
R5291 T6335 T6334 arg2Of 5D,and
R5292 T6336 T6331 arg3Of ),(
R5293 T6338 T6337 arg2Of sequencing,After
R5294 T6338 T6339 arg1Of sequencing,of
R5295 T6342 T6339 arg2Of promoter,of
R5296 T6342 T6340 arg1Of promoter,the
R5297 T6342 T6341 arg1Of promoter,IRF-4
R5298 T6344 T6345 arg1Of it,could
R5299 T6344 T6346 arg1Of it,be
R5300 T6346 T6337 arg1Of be,After
R5301 T6346 T6343 arg1Of be,","
R5302 T6346 T6345 arg2Of be,could
R5303 T6346 T6353 arg1Of be,in
R5304 T6349 T6346 arg2Of absence,be
R5305 T6349 T6347 arg2Of absence,excluded
R5306 T6349 T6348 arg1Of absence,that
R5307 T6349 T6350 arg1Of absence,of
R5308 T6352 T6350 arg2Of expression,of
R5309 T6352 T6351 arg1Of expression,IRF-4
R5310 T6354 T6355 arg1Of any,of
R5311 T6354 T6360 arg1Of any,was
R5312 T6354 T6361 arg1Of any,due
R5313 T6359 T6355 arg2Of lines,of
R5314 T6359 T6356 arg1Of lines,the
R5315 T6359 T6357 arg1Of lines,above
R5316 T6359 T6358 arg1Of lines,cell
R5317 T6360 T6353 arg2Of was,in
R5318 T6361 T6360 arg2Of due,was
R5319 T6361 T6362 arg1Of due,to
R5320 T6364 T6362 arg2Of aberrations,to
R5321 T6364 T6363 arg1Of aberrations,genetic
R5322 T6369 T6367 arg1Of changes,2
R5323 T6369 T6368 arg1Of changes,bp
R5324 T6369 T6370 arg1Of changes,(
R5325 T6369 T6380 arg1Of changes,could
R5326 T6369 T6381 arg1Of changes,be
R5327 T6369 T6382 arg2Of changes,detected
R5328 T6372 T6371 arg1Of −1081,nucleotide
R5329 T6372 T6373 arg1Of −1081,","
R5330 T6373 T6375 arg1Of ",",and
R5331 T6374 T6373 arg2Of T→C,","
R5332 T6375 T6370 arg2Of and,(
R5333 T6375 T6377 arg1Of and,","
R5334 T6376 T6375 arg2Of −1068,and
R5335 T6378 T6377 arg2Of A→C,","
R5336 T6379 T6370 arg3Of ),(
R5337 T6382 T6365 arg1Of detected,However
R5338 T6382 T6366 arg1Of detected,","
R5339 T6382 T6380 arg2Of detected,could
R5340 T6382 T6381 arg2Of detected,be
R5341 T6382 T6383 arg1Of detected,in
R5342 T6387 T6385 arg1Of BV-173,the
R5343 T6387 T6386 arg1Of BV-173,IRF-4-positive
R5344 T6387 T6388 arg1Of BV-173,and
R5345 T6388 T6383 arg2Of and,in
R5346 T6388 T6384 arg1Of and,both
R5347 T6388 T6392 arg1Of and,","
R5348 T6391 T6388 arg2Of LAMA-84,and
R5349 T6391 T6389 arg1Of LAMA-84,the
R5350 T6391 T6390 arg1Of LAMA-84,IRF-4-negative
R5351 T6393 T6394 arg1Of EM-2,and
R5352 T6394 T6392 arg2Of and,","
R5353 T6394 T6396 arg1Of and,(
R5354 T6395 T6394 arg2Of K-562,and
R5355 T6398 T6396 arg2Of 1B,(
R5356 T6398 T6397 arg1Of 1B,Figure
R5357 T6399 T6396 arg3Of ),(
R5358 T6401 T6400 arg2Of position,At
R5359 T6401 T6402 arg1Of position,−116
R5360 T6405 T6403 arg1Of substitution,an
R5361 T6405 T6404 arg1Of substitution,A→C
R5362 T6405 T6406 arg1Of substitution,was
R5363 T6405 T6407 arg2Of substitution,found
R5364 T6407 T6400 arg1Of found,At
R5365 T6407 T6406 arg2Of found,was
R5366 T6407 T6408 arg1Of found,in
R5367 T6407 T6415 arg1Of found,whereas
R5368 T6409 T6410 arg1Of EM-2,","
R5369 T6410 T6412 arg1Of ",",and
R5370 T6411 T6410 arg2Of K-562,","
R5371 T6412 T6408 arg2Of and,in
R5372 T6413 T6412 arg2Of CML-T1,and
R5373 T6415 T6414 arg1Of whereas,","
R5374 T6416 T6417 arg1Of Jurkat,","
R5375 T6417 T6419 arg1Of ",",and
R5376 T6418 T6417 arg2Of BV-173,","
R5377 T6419 T6421 arg1Of and,exhibited
R5378 T6420 T6419 arg2Of SD-1,and
R5379 T6421 T6415 arg2Of exhibited,whereas
R5380 T6422 T6431 arg1Of a,RPMI-8226
R5381 T6425 T6423 arg2Of sequence,mixed
R5382 T6425 T6424 arg1Of sequence,A/C
R5383 T6425 T6426 arg1Of sequence,and
R5384 T6426 T6421 arg2Of and,exhibited
R5385 T6426 T6422 arg1Of and,a
R5386 T6426 T6434 arg1Of and,at
R5387 T6426 T6436 arg1Of and,(
R5388 T6427 T6428 arg1Of U-937,","
R5389 T6428 T6430 arg1Of ",",and
R5390 T6429 T6428 arg2Of LAMA-84,","
R5391 T6430 T6426 arg2Of and,and
R5392 T6431 T6430 arg2Of RPMI-8226,and
R5393 T6433 T6431 arg2Of substitution,RPMI-8226
R5394 T6433 T6432 arg1Of substitution,no
R5395 T6434 T6435 arg1Of at,all
R5396 T6438 T6436 arg2Of 1B,(
R5397 T6438 T6437 arg1Of 1B,Figure
R5398 T6439 T6436 arg3Of ),(
R5399 T6443 T6442 arg1Of alterations,these
R5400 T6443 T6444 arg1Of alterations,are
R5401 T6443 T6445 arg1Of alterations,unlikely
R5402 T6443 T6447 arg1Of alterations,affect
R5403 T6444 T6440 arg1Of are,Consequently
R5404 T6444 T6441 arg1Of are,","
R5405 T6445 T6444 arg2Of unlikely,are
R5406 T6447 T6445 arg2Of affect,unlikely
R5407 T6447 T6446 arg1Of affect,to
R5408 T6449 T6447 arg2Of expression,affect
R5409 T6449 T6448 arg1Of expression,IRF-4

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T6468 0-7 NN denotes Absence
T6469 8-10 IN denotes of
T6470 11-16 NN denotes IRF-4
T6471 17-27 NN denotes expression
T6472 28-30 IN denotes in
T6473 31-39 NN denotes leukemia
T6474 40-45 NNS denotes cells
T6475 46-48 VBZ denotes is
T6476 49-52 RB denotes not
T6477 53-56 JJ denotes due
T6478 57-59 TO denotes to
T6479 60-68 NN denotes promoter
T6480 69-80 NNS denotes alterations
T6481 81-83 PRP denotes We
T6482 84-88 VBP denotes have
T6483 89-99 RB denotes previously
T6484 100-112 VBN denotes demonstrated
T6485 113-114 DT denotes a
T6486 115-119 NN denotes lack
T6487 120-122 IN denotes of
T6488 123-128 NN denotes IRF-4
T6489 129-139 NN denotes expression
T6490 140-142 IN denotes in
T6491 143-151 NN denotes leukemia
T6492 152-160 NNS denotes patients
T6493 161-164 CC denotes and
T6494 165-177 RB denotes specifically
T6495 178-180 IN denotes in
T6496 181-184 NNP denotes CML
T6497 185-192 NNS denotes T-cells
T6498 193-194 -LRB- denotes (
T6499 194-195 CD denotes 3
T6500 195-196 -RRB- denotes )
T6501 196-197 . denotes .
T6502 198-202 RB denotes Here
T6503 202-203 , denotes ,
T6504 204-206 PRP denotes we
T6505 207-218 VBP denotes demonstrate
T6506 219-222 DT denotes the
T6507 223-230 NN denotes absence
T6508 231-233 IN denotes of
T6509 234-239 NN denotes IRF-4
T6510 240-250 NN denotes expression
T6511 251-253 IN denotes in
T6512 254-261 JJ denotes various
T6513 262-275 JJ denotes hematopoietic
T6514 276-280 NN denotes cell
T6515 281-286 NNS denotes lines
T6516 286-287 , denotes ,
T6517 288-292 JJ denotes such
T6518 293-295 IN denotes as
T6519 296-302 NNP denotes Jurkat
T6520 302-303 , denotes ,
T6521 304-305 DT denotes a
T6522 306-312 NNP denotes T-cell
T6523 313-321 NN denotes leukemia
T6524 321-322 , denotes ,
T6525 323-329 NNP denotes CML-T1
T6526 329-330 , denotes ,
T6527 331-332 DT denotes a
T6528 333-349 JJ denotes bcr-abl-positive
T6529 350-356 NNP denotes T-cell
T6530 357-361 NN denotes line
T6531 361-362 , denotes ,
T6532 363-368 NNP denotes K-562
T6533 368-369 , denotes ,
T6534 370-371 DT denotes a
T6535 372-387 JJ denotes bcr-abl-positve
T6536 388-403 NN denotes erythroleukemia
T6537 403-404 , denotes ,
T6538 405-410 NNP denotes U-937
T6539 410-411 , denotes ,
T6540 412-413 DT denotes a
T6541 414-423 JJ denotes monocytic
T6542 424-432 NN denotes leukemia
T6543 432-433 , denotes ,
T6544 434-438 NN denotes EM-2
T6545 439-442 CC denotes and
T6546 443-450 NN denotes LAMA-84
T6547 450-451 , denotes ,
T6548 452-467 JJ denotes bcr-abl-positve
T6549 468-475 JJ denotes myeloid
T6550 476-484 NN denotes leukemia
T6551 484-485 , denotes ,
T6552 486-489 CC denotes but
T6553 490-493 RB denotes not
T6554 494-496 IN denotes in
T6555 497-501 NN denotes SD-1
T6556 501-502 , denotes ,
T6557 503-504 DT denotes a
T6558 505-521 JJ denotes bcr-abl-positive
T6559 522-527 JJ denotes acute
T6560 528-541 JJ denotes lymphoblastic
T6561 542-550 NN denotes leukemia
T6562 551-552 -LRB- denotes (
T6563 552-555 FW denotes pre
T6564 556-561 NNP denotes B-ALL
T6565 561-562 -RRB- denotes )
T6566 562-563 , denotes ,
T6567 564-573 NNP denotes RPMI-8226
T6568 573-574 , denotes ,
T6569 575-576 DT denotes a
T6570 577-585 JJ denotes multiple
T6571 586-593 NN denotes myeloma
T6572 594-597 CC denotes and
T6573 598-604 NN denotes BV-173
T6574 604-605 , denotes ,
T6575 606-607 DT denotes a
T6576 608-624 JJ denotes bcr-abl-positive
T6577 625-631 NNP denotes B-cell
T6578 632-636 NN denotes line
T6579 637-638 -LRB- denotes (
T6580 638-645 NNS denotes Figures
T6581 646-648 NNP denotes 1A
T6582 649-652 CC denotes and
T6583 653-655 NNP denotes 5D
T6584 655-656 -RRB- denotes )
T6585 656-657 . denotes .
T6586 658-663 IN denotes After
T6587 664-674 VBG denotes sequencing
T6588 675-677 IN denotes of
T6589 678-681 DT denotes the
T6590 682-687 NN denotes IRF-4
T6591 688-696 NN denotes promoter
T6592 696-697 , denotes ,
T6593 698-700 PRP denotes it
T6594 701-706 MD denotes could
T6595 707-709 VB denotes be
T6596 710-718 VBN denotes excluded
T6597 719-723 IN denotes that
T6598 724-731 NN denotes absence
T6599 732-734 IN denotes of
T6600 735-740 NN denotes IRF-4
T6601 741-751 NN denotes expression
T6602 752-754 IN denotes in
T6603 755-758 DT denotes any
T6604 759-761 IN denotes of
T6605 762-765 DT denotes the
T6606 766-771 JJ denotes above
T6607 772-776 NN denotes cell
T6608 777-782 NNS denotes lines
T6609 783-786 VBD denotes was
T6610 787-790 JJ denotes due
T6611 791-793 TO denotes to
T6612 794-801 JJ denotes genetic
T6613 802-813 NNS denotes aberrations
T6614 813-814 . denotes .
T6615 815-822 RB denotes However
T6616 822-823 , denotes ,
T6617 824-825 CD denotes 2
T6618 826-828 NN denotes bp
T6619 829-836 NNS denotes changes
T6620 837-838 -LRB- denotes (
T6621 838-848 JJ denotes nucleotide
T6622 849-850 NN denotes −
T6623 850-854 CD denotes 1081
T6624 854-855 , denotes ,
T6625 856-857 NNP denotes T
T6626 857-858 VBD denotes →
T6627 858-859 NNP denotes C
T6628 860-863 CC denotes and
T6629 864-865 NNP denotes −
T6630 865-869 CD denotes 1068
T6631 869-870 , denotes ,
T6632 871-872 DT denotes A
T6633 872-873 NN denotes →
T6634 873-874 NNP denotes C
T6635 874-875 -RRB- denotes )
T6636 876-881 MD denotes could
T6637 882-884 VB denotes be
T6638 885-893 VBN denotes detected
T6639 894-896 IN denotes in
T6640 897-901 DT denotes both
T6641 902-905 DT denotes the
T6642 906-920 JJ denotes IRF-4-positive
T6643 921-927 NN denotes BV-173
T6644 928-931 CC denotes and
T6645 932-935 DT denotes the
T6646 936-950 JJ denotes IRF-4-negative
T6647 951-958 NN denotes LAMA-84
T6648 958-959 , denotes ,
T6649 960-964 NN denotes EM-2
T6650 965-968 CC denotes and
T6651 969-974 NN denotes K-562
T6652 975-976 -LRB- denotes (
T6653 976-982 NN denotes Figure
T6654 983-985 NN denotes 1B
T6655 985-986 -RRB- denotes )
T6656 986-987 . denotes .
T6657 988-990 IN denotes At
T6658 991-999 NN denotes position
T6659 1000-1001 NN denotes −
T6660 1001-1004 CD denotes 116
T6661 1005-1007 DT denotes an
T6662 1008-1009 DT denotes A
T6663 1009-1010 NN denotes →
T6664 1010-1011 NNP denotes C
T6665 1012-1024 NN denotes substitution
T6666 1025-1028 VBD denotes was
T6667 1029-1034 VBN denotes found
T6668 1035-1037 IN denotes in
T6669 1038-1042 NNP denotes EM-2
T6670 1042-1043 , denotes ,
T6671 1044-1049 NNP denotes K-562
T6672 1050-1053 CC denotes and
T6673 1054-1060 NNP denotes CML-T1
T6674 1060-1061 , denotes ,
T6675 1062-1069 IN denotes whereas
T6676 1070-1076 NNP denotes Jurkat
T6677 1076-1077 , denotes ,
T6678 1078-1084 NNP denotes BV-173
T6679 1085-1088 CC denotes and
T6680 1089-1093 NNP denotes SD-1
T6681 1094-1103 VBD denotes exhibited
T6682 1104-1105 DT denotes a
T6683 1106-1111 JJ denotes mixed
T6684 1112-1115 NNP denotes A/C
T6685 1116-1124 NN denotes sequence
T6686 1125-1128 CC denotes and
T6687 1129-1134 NNP denotes U-937
T6688 1134-1135 , denotes ,
T6689 1136-1143 NNP denotes LAMA-84
T6690 1144-1147 CC denotes and
T6691 1148-1157 NNP denotes RPMI-8226
T6692 1158-1160 DT denotes no
T6693 1161-1173 NN denotes substitution
T6694 1174-1176 IN denotes at
T6695 1177-1180 DT denotes all
T6696 1181-1182 -LRB- denotes (
T6697 1182-1188 NN denotes Figure
T6698 1189-1191 NN denotes 1B
T6699 1191-1192 -RRB- denotes )
T6700 1192-1193 . denotes .
T6701 1194-1206 RB denotes Consequently
T6702 1206-1207 , denotes ,
T6703 1208-1213 DT denotes these
T6704 1214-1225 NNS denotes alterations
T6705 1226-1229 VBP denotes are
T6706 1230-1238 JJ denotes unlikely
T6707 1239-1241 TO denotes to
T6708 1242-1248 VB denotes affect
T6709 1249-1254 JJ denotes IRF-4
T6710 1255-1265 NN denotes expression
T6711 1265-1266 . denotes .
R5410 T6468 T6475 nsubj Absence,is
R5411 T6469 T6468 prep of,Absence
R5412 T6470 T6471 compound IRF-4,expression
R5413 T6471 T6469 pobj expression,of
R5414 T6472 T6468 prep in,Absence
R5415 T6473 T6474 compound leukemia,cells
R5416 T6474 T6472 pobj cells,in
R5417 T6475 T6475 ROOT is,is
R5418 T6476 T6475 neg not,is
R5419 T6477 T6475 acomp due,is
R5420 T6478 T6479 aux to,promoter
R5421 T6479 T6477 xcomp promoter,due
R5422 T6480 T6475 conj alterations,is
R5423 T6481 T6484 nsubj We,demonstrated
R5424 T6482 T6484 aux have,demonstrated
R5425 T6483 T6484 advmod previously,demonstrated
R5426 T6484 T6480 relcl demonstrated,alterations
R5427 T6485 T6486 det a,lack
R5428 T6486 T6484 dobj lack,demonstrated
R5429 T6487 T6486 prep of,lack
R5430 T6488 T6489 compound IRF-4,expression
R5431 T6489 T6487 pobj expression,of
R5432 T6490 T6484 prep in,demonstrated
R5433 T6491 T6492 compound leukemia,patients
R5434 T6492 T6490 pobj patients,in
R5435 T6493 T6484 cc and,demonstrated
R5436 T6494 T6495 advmod specifically,in
R5437 T6495 T6484 conj in,demonstrated
R5438 T6496 T6497 compound CML,T-cells
R5439 T6497 T6495 pobj T-cells,in
R5440 T6498 T6497 punct (,T-cells
R5441 T6499 T6497 appos 3,T-cells
R5442 T6500 T6497 punct ),T-cells
R5443 T6501 T6475 punct .,is
R5444 T6502 T6505 advmod Here,demonstrate
R5445 T6503 T6505 punct ",",demonstrate
R5446 T6504 T6505 nsubj we,demonstrate
R5447 T6505 T6505 ROOT demonstrate,demonstrate
R5448 T6506 T6507 det the,absence
R5449 T6507 T6505 dobj absence,demonstrate
R5450 T6508 T6507 prep of,absence
R5451 T6509 T6510 compound IRF-4,expression
R5452 T6510 T6508 pobj expression,of
R5453 T6511 T6507 prep in,absence
R5454 T6512 T6515 amod various,lines
R5455 T6513 T6515 amod hematopoietic,lines
R5456 T6514 T6515 compound cell,lines
R5457 T6515 T6511 pobj lines,in
R5458 T6516 T6515 punct ",",lines
R5459 T6517 T6518 amod such,as
R5460 T6518 T6515 prep as,lines
R5461 T6519 T6518 pobj Jurkat,as
R5462 T6520 T6519 punct ",",Jurkat
R5463 T6521 T6523 det a,leukemia
R5464 T6522 T6523 compound T-cell,leukemia
R5465 T6523 T6519 conj leukemia,Jurkat
R5466 T6524 T6523 punct ",",leukemia
R5467 T6525 T6561 nmod CML-T1,leukemia
R5468 T6526 T6525 punct ",",CML-T1
R5469 T6527 T6530 det a,line
R5470 T6528 T6530 amod bcr-abl-positive,line
R5471 T6529 T6530 compound T-cell,line
R5472 T6530 T6525 appos line,CML-T1
R5473 T6531 T6532 punct ",",K-562
R5474 T6532 T6525 conj K-562,CML-T1
R5475 T6533 T6532 punct ",",K-562
R5476 T6534 T6536 det a,erythroleukemia
R5477 T6535 T6536 amod bcr-abl-positve,erythroleukemia
R5478 T6536 T6532 appos erythroleukemia,K-562
R5479 T6537 T6536 punct ",",erythroleukemia
R5480 T6538 T6536 conj U-937,erythroleukemia
R5481 T6539 T6538 punct ",",U-937
R5482 T6540 T6542 det a,leukemia
R5483 T6541 T6542 amod monocytic,leukemia
R5484 T6542 T6538 appos leukemia,U-937
R5485 T6543 T6542 punct ",",leukemia
R5486 T6544 T6542 conj EM-2,leukemia
R5487 T6545 T6544 cc and,EM-2
R5488 T6546 T6544 conj LAMA-84,EM-2
R5489 T6547 T6546 punct ",",LAMA-84
R5490 T6548 T6550 amod bcr-abl-positve,leukemia
R5491 T6549 T6550 amod myeloid,leukemia
R5492 T6550 T6546 conj leukemia,LAMA-84
R5493 T6551 T6550 punct ",",leukemia
R5494 T6552 T6550 cc but,leukemia
R5495 T6553 T6554 neg not,in
R5496 T6554 T6542 prep in,leukemia
R5497 T6555 T6554 pobj SD-1,in
R5498 T6556 T6554 punct ",",in
R5499 T6557 T6561 det a,leukemia
R5500 T6558 T6561 amod bcr-abl-positive,leukemia
R5501 T6559 T6561 amod acute,leukemia
R5502 T6560 T6561 amod lymphoblastic,leukemia
R5503 T6561 T6523 appos leukemia,leukemia
R5504 T6562 T6564 punct (,B-ALL
R5505 T6563 T6564 compound pre,B-ALL
R5506 T6564 T6561 appos B-ALL,leukemia
R5507 T6565 T6564 punct ),B-ALL
R5508 T6566 T6561 punct ",",leukemia
R5509 T6567 T6561 appos RPMI-8226,leukemia
R5510 T6568 T6567 punct ",",RPMI-8226
R5511 T6569 T6571 det a,myeloma
R5512 T6570 T6571 amod multiple,myeloma
R5513 T6571 T6567 appos myeloma,RPMI-8226
R5514 T6572 T6571 cc and,myeloma
R5515 T6573 T6571 conj BV-173,myeloma
R5516 T6574 T6573 punct ",",BV-173
R5517 T6575 T6578 det a,line
R5518 T6576 T6578 amod bcr-abl-positive,line
R5519 T6577 T6578 compound B-cell,line
R5520 T6578 T6573 appos line,BV-173
R5521 T6579 T6581 punct (,1A
R5522 T6580 T6581 compound Figures,1A
R5523 T6581 T6578 appos 1A,line
R5524 T6582 T6581 cc and,1A
R5525 T6583 T6581 conj 5D,1A
R5526 T6584 T6581 punct ),1A
R5527 T6585 T6505 punct .,demonstrate
R5528 T6586 T6596 prep After,excluded
R5529 T6587 T6586 pcomp sequencing,After
R5530 T6588 T6587 prep of,sequencing
R5531 T6589 T6591 det the,promoter
R5532 T6590 T6591 compound IRF-4,promoter
R5533 T6591 T6588 pobj promoter,of
R5534 T6592 T6596 punct ",",excluded
R5535 T6593 T6596 nsubjpass it,excluded
R5536 T6594 T6596 aux could,excluded
R5537 T6595 T6596 auxpass be,excluded
R5538 T6596 T6596 ROOT excluded,excluded
R5539 T6597 T6598 det that,absence
R5540 T6598 T6596 dobj absence,excluded
R5541 T6599 T6598 prep of,absence
R5542 T6600 T6601 compound IRF-4,expression
R5543 T6601 T6599 pobj expression,of
R5544 T6602 T6596 prep in,excluded
R5545 T6603 T6602 pobj any,in
R5546 T6604 T6603 prep of,any
R5547 T6605 T6608 det the,lines
R5548 T6606 T6608 amod above,lines
R5549 T6607 T6608 compound cell,lines
R5550 T6608 T6604 pobj lines,of
R5551 T6609 T6596 conj was,excluded
R5552 T6610 T6609 acomp due,was
R5553 T6611 T6610 xcomp to,due
R5554 T6612 T6613 amod genetic,aberrations
R5555 T6613 T6611 pobj aberrations,to
R5556 T6614 T6596 punct .,excluded
R5557 T6615 T6638 advmod However,detected
R5558 T6616 T6638 punct ",",detected
R5559 T6617 T6619 nummod 2,changes
R5560 T6618 T6619 compound bp,changes
R5561 T6619 T6638 nsubjpass changes,detected
R5562 T6620 T6619 punct (,changes
R5563 T6621 T6622 amod nucleotide,−
R5564 T6622 T6619 appos −,changes
R5565 T6623 T6622 appos 1081,−
R5566 T6624 T6638 punct ",",detected
R5567 T6625 T6638 nsubj T,detected
R5568 T6626 T6638 parataxis →,detected
R5569 T6627 T6626 dobj C,→
R5570 T6628 T6627 cc and,C
R5571 T6629 T6627 conj −,C
R5572 T6630 T6627 appos 1068,C
R5573 T6631 T6627 punct ",",C
R5574 T6632 T6634 det A,C
R5575 T6633 T6634 compound →,C
R5576 T6634 T6627 appos C,C
R5577 T6635 T6627 punct ),C
R5578 T6636 T6638 aux could,detected
R5579 T6637 T6638 auxpass be,detected
R5580 T6638 T6638 ROOT detected,detected
R5581 T6639 T6638 prep in,detected
R5582 T6640 T6643 preconj both,BV-173
R5583 T6641 T6643 det the,BV-173
R5584 T6642 T6643 compound IRF-4-positive,BV-173
R5585 T6643 T6639 pobj BV-173,in
R5586 T6644 T6643 cc and,BV-173
R5587 T6645 T6647 det the,LAMA-84
R5588 T6646 T6647 amod IRF-4-negative,LAMA-84
R5589 T6647 T6643 conj LAMA-84,BV-173
R5590 T6648 T6647 punct ",",LAMA-84
R5591 T6649 T6647 conj EM-2,LAMA-84
R5592 T6650 T6649 cc and,EM-2
R5593 T6651 T6649 conj K-562,EM-2
R5594 T6652 T6654 punct (,1B
R5595 T6653 T6654 compound Figure,1B
R5596 T6654 T6651 appos 1B,K-562
R5597 T6655 T6654 punct ),1B
R5598 T6656 T6638 punct .,detected
R5599 T6657 T6667 prep At,found
R5600 T6658 T6659 compound position,−
R5601 T6659 T6657 pobj −,At
R5602 T6660 T6659 nummod 116,−
R5603 T6661 T6665 det an,substitution
R5604 T6662 T6665 det A,substitution
R5605 T6663 T6665 amod →,substitution
R5606 T6664 T6665 compound C,substitution
R5607 T6665 T6667 nsubjpass substitution,found
R5608 T6666 T6667 auxpass was,found
R5609 T6667 T6667 ROOT found,found
R5610 T6668 T6667 prep in,found
R5611 T6669 T6668 pobj EM-2,in
R5612 T6670 T6669 punct ",",EM-2
R5613 T6671 T6669 conj K-562,EM-2
R5614 T6672 T6671 cc and,K-562
R5615 T6673 T6671 conj CML-T1,K-562
R5616 T6674 T6667 punct ",",found
R5617 T6675 T6681 mark whereas,exhibited
R5618 T6676 T6681 nsubj Jurkat,exhibited
R5619 T6677 T6676 punct ",",Jurkat
R5620 T6678 T6676 conj BV-173,Jurkat
R5621 T6679 T6678 cc and,BV-173
R5622 T6680 T6678 conj SD-1,BV-173
R5623 T6681 T6667 advcl exhibited,found
R5624 T6682 T6685 det a,sequence
R5625 T6683 T6685 amod mixed,sequence
R5626 T6684 T6685 compound A/C,sequence
R5627 T6685 T6681 dobj sequence,exhibited
R5628 T6686 T6685 cc and,sequence
R5629 T6687 T6685 conj U-937,sequence
R5630 T6688 T6687 punct ",",U-937
R5631 T6689 T6687 conj LAMA-84,U-937
R5632 T6690 T6689 cc and,LAMA-84
R5633 T6691 T6689 conj RPMI-8226,LAMA-84
R5634 T6692 T6693 det no,substitution
R5635 T6693 T6685 conj substitution,sequence
R5636 T6694 T6695 advmod at,all
R5637 T6695 T6693 advmod all,substitution
R5638 T6696 T6698 punct (,1B
R5639 T6697 T6698 compound Figure,1B
R5640 T6698 T6693 appos 1B,substitution
R5641 T6699 T6698 punct ),1B
R5642 T6700 T6667 punct .,found
R5643 T6701 T6705 advmod Consequently,are
R5644 T6702 T6705 punct ",",are
R5645 T6703 T6704 det these,alterations
R5646 T6704 T6705 nsubj alterations,are
R5647 T6705 T6705 ROOT are,are
R5648 T6706 T6705 acomp unlikely,are
R5649 T6707 T6708 aux to,affect
R5650 T6708 T6706 xcomp affect,unlikely
R5651 T6709 T6710 amod IRF-4,expression
R5652 T6710 T6708 dobj expression,affect
R5653 T6711 T6705 punct .,are

UBERON-AE

Id Subject Object Predicate Lexical cue
T6183 556-561 http://purl.obolibrary.org/obo/UBERON_2000006 denotes B-ALL

ICD10

Id Subject Object Predicate Lexical cue
T6719 577-593 http://purl.bioontology.org/ontology/ICD10/C90.0 denotes multiple myeloma

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T6847 11-16 Protein denotes IRF-4
T6848 17-27 Gene_expression denotes expression
T6849 0-7 Negative_regulation denotes Absence
T6850 53-56 Positive_regulation denotes due
T6851 123-128 Protein denotes IRF-4
T6852 129-139 Gene_expression denotes expression
T6853 115-119 Negative_regulation denotes lack
T6854 234-239 Protein denotes IRF-4
T6855 333-336 Protein denotes bcr
T6856 337-340 Protein denotes abl
T6857 372-375 Protein denotes bcr
T6858 376-379 Protein denotes abl
T6859 434-438 Protein denotes EM-2
T6860 443-450 Protein denotes LAMA-84
T6861 452-455 Protein denotes bcr
T6862 456-459 Protein denotes abl
T6863 505-508 Protein denotes bcr
T6864 509-512 Protein denotes abl
T6865 608-611 Protein denotes bcr
T6866 612-615 Protein denotes abl
T6867 240-250 Gene_expression denotes expression
T6868 341-349 Gene_expression denotes positive
T6869 341-349 Gene_expression denotes positive
T6870 380-387 Gene_expression denotes positve
T6871 380-387 Gene_expression denotes positve
T6872 460-467 Gene_expression denotes positve
T6873 460-467 Gene_expression denotes positve
T6874 513-521 Gene_expression denotes positive
T6875 513-521 Gene_expression denotes positive
T6876 616-624 Gene_expression denotes positive
T6877 616-624 Gene_expression denotes positive
T6878 682-696 Protein denotes IRF-4 promoter
T6879 735-740 Protein denotes IRF-4
T6880 741-751 Gene_expression denotes expression
T6881 724-731 Negative_regulation denotes absence
T6882 906-911 Protein denotes IRF-4
T6883 912-920 Gene_expression denotes positive
T6884 1249-1254 Protein denotes IRF-4
T6885 1255-1265 Gene_expression denotes expression
T6886 1242-1248 Regulation denotes affect
R5722 T6847 T6848 themeOf IRF-4,expression
R5723 T6848 T6849 themeOf expression,Absence
R5724 T6849 T6850 themeOf Absence,due
R5725 T6851 T6852 themeOf IRF-4,expression
R5726 T6852 T6853 themeOf expression,lack
R5727 T6854 T6867 themeOf IRF-4,expression
R5728 T6855 T6868 themeOf bcr,positive
R5729 T6856 T6869 themeOf abl,positive
R5730 T6857 T6870 themeOf bcr,positve
R5731 T6858 T6871 themeOf abl,positve
R5732 T6861 T6872 themeOf bcr,positve
R5733 T6862 T6873 themeOf abl,positve
R5734 T6863 T6874 themeOf bcr,positive
R5735 T6864 T6875 themeOf abl,positive
R5736 T6865 T6876 themeOf bcr,positive
R5737 T6866 T6877 themeOf abl,positive
R5738 T6879 T6880 themeOf IRF-4,expression
R5739 T6880 T6881 themeOf expression,absence
R5740 T6882 T6883 themeOf IRF-4,positive
R5741 T6884 T6885 themeOf IRF-4,expression
R5742 T6885 T6886 themeOf expression,affect

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation Speculation
T6190 129-139 Gene_expression denotes expression
T6191 234-239 Protein denotes IRF-4
T6192 240-250 Gene_expression denotes expression true
T6193 333-340 Protein denotes bcr-abl
T6194 341-349 Gene_expression denotes positive
T6195 372-379 Protein denotes bcr-abl
T6196 380-387 Gene_expression denotes positve
T6197 452-459 Protein denotes bcr-abl
T6198 460-467 Gene_expression denotes positve
T6199 505-512 Protein denotes bcr-abl
T6200 513-521 Gene_expression denotes positive
T6201 608-615 Protein denotes bcr-abl
T6202 616-624 Gene_expression denotes positive
T6203 682-687 Protein denotes IRF-4
T6204 724-731 Negative_regulation denotes absence
T6205 735-740 Protein denotes IRF-4
T6206 741-751 Gene_expression denotes expression
T6207 906-911 Protein denotes IRF-4
T6208 912-920 Gene_expression denotes positive
T6209 936-941 Protein denotes IRF-4
T6210 942-950 Gene_expression denotes negative true
T6211 1242-1248 Regulation denotes affect true true
T6212 1249-1254 Protein denotes IRF-4
T6213 1255-1265 Gene_expression denotes expression
T6184 0-7 Negative_regulation denotes Absence
T6185 11-16 Protein denotes IRF-4
T6186 17-27 Gene_expression denotes expression
T6187 53-56 Positive_regulation denotes due true
T6188 115-119 Negative_regulation denotes lack
T6189 123-128 Protein denotes IRF-4
R5171 T6206 T6204 themeOf expression,absence
R5172 T6207 T6208 themeOf IRF-4,positive
R5173 T6209 T6210 themeOf IRF-4,negative
R5174 T6212 T6213 themeOf IRF-4,expression
R5175 T6213 T6211 themeOf expression,affect
R5159 T6184 T6187 themeOf Absence,due
R5160 T6185 T6186 themeOf IRF-4,expression
R5161 T6186 T6184 themeOf expression,Absence
R5162 T6189 T6190 themeOf IRF-4,expression
R5163 T6190 T6188 themeOf expression,lack
R5164 T6191 T6192 themeOf IRF-4,expression
R5165 T6193 T6194 themeOf bcr-abl,positive
R5166 T6195 T6196 themeOf bcr-abl,positve
R5167 T6197 T6198 themeOf bcr-abl,positve
R5168 T6199 T6200 themeOf bcr-abl,positive
R5169 T6201 T6202 themeOf bcr-abl,positive
R5170 T6205 T6206 themeOf IRF-4,expression

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T6450 11-16 Q15306 denotes IRF-4
T6451 123-128 Q15306 denotes IRF-4
T6452 234-239 Q15306 denotes IRF-4
T6453 333-336 P11274 denotes bcr
T6454 337-340 P00519 denotes abl
T6455 372-375 P11274 denotes bcr
T6456 376-379 P00519 denotes abl
T6457 452-455 P11274 denotes bcr
T6458 456-459 P00519 denotes abl
T6459 505-508 P11274 denotes bcr
T6460 509-512 P00519 denotes abl
T6461 608-611 P11274 denotes bcr
T6462 612-615 P00519 denotes abl
T6463 682-687 Q15306 denotes IRF-4
T6464 735-740 Q15306 denotes IRF-4
T6465 906-911 Q15306 denotes IRF-4
T6466 936-941 Q15306 denotes IRF-4
T6467 1249-1254 Q15306 denotes IRF-4

test2

Id Subject Object Predicate Lexical cue Negation Speculation
T6152 0-7 Negative_regulation denotes Absence
T6153 11-16 Protein denotes IRF-4
T6154 17-27 Gene_expression denotes expression true
T6155 53-56 Positive_regulation denotes due
T6156 115-119 Negative_regulation denotes lack
T6157 123-128 Protein denotes IRF-4 true
T6158 129-139 Gene_expression denotes expression
T6159 223-230 Negative_regulation denotes absence
T6160 234-239 Protein denotes IRF-4
T6161 240-250 Gene_expression denotes expression
T6162 333-340 Protein denotes bcr-abl
T6163 341-349 Gene_expression denotes positive
T6164 372-379 Protein denotes bcr-abl
T6165 380-387 Gene_expression denotes positve
T6166 452-459 Protein denotes bcr-abl true
T6167 460-467 Gene_expression denotes positve true true
T6168 505-512 Protein denotes bcr-abl
T6169 513-521 Gene_expression denotes positive
T6170 608-615 Protein denotes bcr-abl
T6171 616-624 Gene_expression denotes positive
T6172 682-687 Protein denotes IRF-4
T6173 724-731 Negative_regulation denotes absence
T6174 735-740 Protein denotes IRF-4
T6175 741-751 Gene_expression denotes expression
T6176 906-911 Protein denotes IRF-4
T6177 912-920 Gene_expression denotes positive
T6178 936-941 Protein denotes IRF-4
T6179 942-950 Gene_expression denotes negative
T6180 1242-1248 Regulation denotes affect
T6181 1249-1254 Protein denotes IRF-4
T6182 1255-1265 Gene_expression denotes expression
R5140 T6152 T6155 themeOf Absence,due
R5141 T6153 T6154 themeOf IRF-4,expression
R5142 T6154 T6152 themeOf expression,Absence
R5143 T6154 T6155 themeOf expression,due
R5144 T6157 T6158 themeOf IRF-4,expression
R5145 T6158 T6156 themeOf expression,lack
R5146 T6160 T6161 themeOf IRF-4,expression
R5147 T6161 T6159 themeOf expression,absence
R5148 T6162 T6163 themeOf bcr-abl,positive
R5149 T6164 T6165 themeOf bcr-abl,positve
R5150 T6166 T6167 themeOf bcr-abl,positve
R5151 T6168 T6169 themeOf bcr-abl,positive
R5152 T6170 T6171 themeOf bcr-abl,positive
R5153 T6174 T6175 themeOf IRF-4,expression
R5154 T6175 T6173 themeOf expression,absence
R5155 T6176 T6177 themeOf IRF-4,positive
R5156 T6178 T6179 themeOf IRF-4,negative
R5157 T6181 T6182 themeOf IRF-4,expression
R5158 T6182 T6180 themeOf expression,affect